References
- Perrin MR, Labropoulos N, Leon LR Jr. Presentation of the patient with recurrent varices after surgery (REVAS). J Vasc Surg. 2006;43:327–334.
- Asciutto G, Asciutto KC, Mumme A, et al. Pelvic venous incompetence: reflux patterns and treatment results. Eur J Vasc Endovasc Surg. 2009;38(3):381–386.
- Creton D, Hennequin L, Kohler F, et al. Embolisation of symptomatic pelvic veins in women presenting with non-saphenous varicose veins of pelvic origin – three-year follow-up. Eur J Vasc Endovasc Surg. 2007;34(1):112–117.
- Whiteley AM, Taylor DC, Dos Santos SJ, et al. Pelvic venous reflux is a major contributory cause of recurrent varicose veins in more than a quarter of women. J Vasc Surg Venous Lymphat Disord. 2014;2(4):411–415.
- Venbrux AC, Chang AH, Kim HS. Pelvic congestion syndrome (pelvic venous incompetence): impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. J Vasc Interv Radiol. 2002;13(2 Pt 1):171–178.
- Lasry JL, Coppe G, Balian E, et al. Pelvi-perineal venous insufficiency and varicose veins of the lower limbs: duplex Doppler diagnosis and endoluminal treatment in thirty females. J Mal Vasc. 2007;32(1):23–31.
- Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–1252.
- Gavrilov SG, Karalkin AV, Turischeva OO. Compression treatment of pelvic congestion syndrome. Phlebology. 2018;33(6):418–424.
- Gloviczki P, Comerota AJ, Dalsing MC, et al.; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S.
- Bush R, Comerota A, Meissner M, et al. Recommendations for the medical management of chronic venous disease: the role of micronized purified flavonoid fraction (MPFF). Phlebology. 2017;32(1 suppl):3–19.
- Rabe E, Agus GB, Roztocil K. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial. Int Angiol. 2015;34(5):428–436.
- Kirienko A, Radak D. Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial. Int Angiol. 2016;35(4):399–405.
- Gavrilov SG, Turischeva OO. Conservative treatment of pelvic congestion syndrome: indications and opportunities. Curr Med Res Opin. 2017;33(6):1099–1103.